Henry Schein | HSIC - Betriebsergebnis

Aktienkurs
70.82
Täglich Wechseln
0.32 0.45%
Monatlich
-6.35%
Jährlich
3.18%
Q2 Prognose
72.39




Betriebsergebnis Veränderung Datum
Agilent USD 353M 90M 2025-12
Align Technology USD 178.05M 46.66M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Cardinal Health USD 861M 98M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cigna USD 2.76B 204M 2026-03
Concord Medical Services Hldg CNY -144.65M 69.38M 2025-06
Cooper Companies USD 212.8M 72.4M 2025-12
CVS Health USD 4.68B 2.57B 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Encompass Health USD 319.1M 35.7M 2026-03
Henry Schein USD 182M 4M 2026-03
Idexx Laboratories USD 362.59M 46.98M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
McKesson USD 1.84B 181M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
Owens Minor USD 814K 28.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Revvity USD 82.77M 63.06M 2026-03
Stryker USD 1.1B 867M 2026-03
Tenet Healthcare USD 1.38B 509M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Universal Health Services USD 502.86M 14.37M 2026-03
Veradigm USD -45.47M 70.47M 2022-12
Waters USD 148M 122.52M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03
Zoetis USD 865M 30M 2026-03